tirofiban and Stroke
tirofiban has been researched along with Stroke in 92 studies
Research
Studies (92)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (16.30) | 29.6817 |
| 2010's | 31 (33.70) | 24.3611 |
| 2020's | 46 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Liu, H; Liu, J; Yang, Y | 1 |
| Huang, X; Jiang, Z; Liu, H; Ren, Y; Sun, Y; Wang, L; Zheng, H | 1 |
| Huang, W; Lei, B; Li, F; Li, H; Liu, W; Nogueira, RG; Qiu, Z; Sang, H; Saver, JL; Yang, Q; Zhang, M; Zhou, P; Zhou, Z; Zi, W | 1 |
| Beaujeux, R; Chibbaro, S; Gheoca, R; Hasiu, A; Mangin, PH; Mihoc, D; Pop, R; Quenardelle, V; Severac, F; Simu, M; Tudor, R; Wolff, V | 1 |
| Cai, YL; Du, B; Du, J; Duan, WB; Kong, XK; Lin, T; Liu, L; Wen, WL; Wu, Z; Yu, YJ | 1 |
| Du, N; Liu, YL; Wang, LX; Yang, L; Yin, XL; Zhao, JS | 1 |
| Gao, Y; Tian, W; Yang, H; Yang, Z; Zhang, T | 1 |
| Hang, Y; Jia, ZY; Liu, S; Ni, H; Shi, HB; Wang, CD; Zhao, LB | 1 |
| Chen, W; Li, T; Li, Z; Liu, J; Wang, S; Xing, P; Yang, P; Zhang, L; Zhang, Y | 1 |
| Bai, Y; Cao, W; Chang, M; Chen, S; Dai, W; Deng, W; Du, J; Fu, X; Ge, H; Guo, F; Guo, Z; Hong, Y; Hu, J; Hu, W; Hu, Z; Huang, C; Huang, J; Huang, W; Huang, X; Jiang, S; Jin, Y; Jin, Z; Ju, D; Ke, Y; Kong, W; Lei, B; Li, F; Li, H; Li, J; Li, L; Li, R; Liu, S; Liu, T; Liu, W; Long, C; Lu, M; Luo, J; Luo, S; Luo, W; Luo, X; Miao, J; Nogueira, RG; Pan, C; Peng, D; Pu, J; Qi, L; Qiu, Z; Sang, H; Saver, JL; Shi, Z; Song, B; Song, J; Sun, D; Sun, Y; Tian, Y; Tian, Z; Wan, Y; Wang, J; Wang, L; Wang, S; Wang, T; Wang, Y; Wei, L; Wen, C; Wen, H; Wu, D; Wu, J; Wu, Y; Xu, X; Yan, Z; Yang, J; Yang, Q; Yang, S; Yu, Y; Yuan, G; Yuan, J; Yuan, Z; Yue, C; Zeng, G; Zeng, H; Zhang, G; Zhang, J; Zhang, M; Zhang, S; Zhao, W; Zheng, B; Zheng, C; Zhou, P; Zhou, Z; Zhu, X; Zi, W | 1 |
| Chen, J; Duan, J; Guo, W; Ji, X; Li, C; Li, S; Ma, J; Ma, L; Ma, Q; Ren, C; Song, H; Wu, C; Wu, L; Xu, J; Zhao, W | 1 |
| Hu, J; Huang, J; Kong, W; Li, F; Li, L; Liu, S; Luo, W; Nogueira, RG; Qiu, Z; Sang, H; Saver, JL; Song, J; Tian, Y; Yang, J; Yang, Q; Zi, W | 1 |
| Chen, S; Deng, S; Li, T; Lin, B; Liu, Q; Lu, X; Pan, L; Peng, R; Shi, S; Weng, B; Xun, W; Yang, H; Zhang, J | 1 |
| Altmann, S; Brockmann, C; Brockmann, MA; Dillinger, D; Kerz, T; Maus, V; Mpotsaris, A; Othman, AE; Ringel, F; Spreer, A; Waldeck, S | 1 |
| Du, Y; Duan, Z; Li, S; Li, Y; Lian, Y; Liu, R; Ma, C; Wang, H | 1 |
| Chen, Q; Dai, W; Deng, W; Feng, X; Fu, Y; Han, Q; Hu, J; Huang, X; Meng, R; Qiu, Z; Sang, H; Tao, Z; Tian, Y; Wang, T; Wu, D; Xie, D; Yuan, J; Zhang, M; Zuo, L | 1 |
| Fei, Y; Lin, S; Lin, Y; Pan, X; Xu, M; Yang, J; Zou, J | 1 |
| Guo, Y; He, C; Shang, X; Yang, K; Zhou, Z; Zi, W | 1 |
| He, ZF; Hou, MM; Li, XY; Liu, XL; Ren, G; Shi, H; Sun, B | 1 |
| Cheng, J; Hou, Y; Hu, Y; Li, G; Liu, C; Shi, Z; Xiao, Q; Yin, L; Zhu, Q | 1 |
| Ji, X; Jin, F; Ma, H; Ma, Q; Wang, Y; Xu, Y; Zhang, Q | 1 |
| Abdalkader, M; Du, J; Gu, G; Guo, Q; Han, Q; Hu, J; Hu, X; Huang, C; Huang, J; Jiang, B; Jin, Y; Li, F; Liu, S; Liu, T; Luo, S; Mao, A; Nguyen, TN; Pu, J; Qiu, Z; Sang, H; Tao, Z; Wang, L; Yan, Z; Yang, J; Zhao, W; Zhou, S; Zi, W | 1 |
| Berlis, A; Ertl, M; Garayzade, R; Maurer, CJ; Müller, G; Schiele, S; Schneider, H | 1 |
| Li, H; Liu, C; Wang, J; Wang, S; Xue, Y | 1 |
| Chang, M; Hu, Z; Ke, Y; Li, F; Li, L; Li, R; Long, C; Nguyen, TN; Nogueira, RG; Peng, D; Qiu, Z; Ruan, J; Sang, H; Saver, JL; Tian, Y; Tian, Z; Wang, T; Wu, D; Wu, J; Xie, D; Yang, Q; Zhu, X; Zi, W | 1 |
| Li, G; Liu, C; Liu, M; Wang, J; Yang, X | 2 |
| Lin, ZH; Zhang, ZM; Zhu, GL | 1 |
| Al-Jebur, MS; Al-Salihi, MM; Al-Salihi, Y; Ayyad, A; Kasab, SA; Kass-Hout, T; Morsi, RZ; Saha, R; Spiotta, AM | 1 |
| Guo, C; Hu, J; Huang, J; Kong, W; Li, F; Li, L; Liu, C; Liu, X; Miao, J; Peng, Z; Saver, JL; Song, J; Tian, Y; Yang, D; Yang, J; Yue, C; Zhang, X; Zi, W | 1 |
| Guan, Q; Li, J; Li, X; Lv, W; Ni, H; Xie, Z; Xu, Y; Yun, W; Zhang, L; Zhang, Q; Zhou, J | 1 |
| Alberts, MJ | 1 |
| Gao, L; Guo, Z; Jiang, J; Li, F; Long, T; Luo, Y; Lv, Z; Meng, R; Qiu, Z; Rong, B; Tian, J; Xie, Y; Yang, Y; Yuan, Z; Zeng, H; Zhang, S; Zhao, J; Zi, W | 1 |
| Cao, PW; Chen, GF; Fu, C; Fu, XM; Wang, L; Zhang, GQ; Zhang, QQ; Zhang, Y | 1 |
| Ding, J; Huang, S; Ji, X; Lian, Y; Ma, Q; Ren, M; Song, H; Sun, C; Wang, L; Wang, Y; Wu, C; Wu, D; Xie, N; Zhao, W | 1 |
| Gong, J; Liu, G; Shang, J; Su, D; Sun, Z; Wan, Q; Yu, H | 1 |
| Cai, J; Cao, J; Ding, C; Qu, M; Shi, Z; Wang, H; Wang, Y; Xia, Y; Yan, Z; Zhang, C; Zhang, X | 1 |
| Chen, W; Gao, F; Huo, X; Ma, N; Miao, Z; Shi, H; Wang, A; Wang, S; Wang, Y; Yang, M | 1 |
| Huang, S; Li, X; Liang, C; Liu, C; Wang, H; Zhang, M | 1 |
| Fu, Z; Gao, L; Liu, X; Wang, Z; Xu, C | 1 |
| Huo, FR; Ma, HB; Shao, SJ; Yang, ZQ; Yin, R; Zhang, GZ; Zhao, L; Zhu, L | 1 |
| Gao, F; Huo, X; Li, X; Ma, N; Miao, Z; Mo, D; Wang, A; Wang, Y; Yang, M | 1 |
| Guo, ZN; Qin, H; Sun, Y; Wang, M; Wang, Y; Yan, X; Yang, Y; Zhang, P; Zhu, H | 1 |
| Bivard, A; Gao, X; Levi, CR; Lin, L; Parsons, MW; Wu, Y; Yang, J | 1 |
| Hadler, F; Nikoubashman, O; Reich, A; Singh, R; Wiesmann, M | 1 |
| Baek, BH; Kim, JT; Kim, SK; Lee, YY; Park, MS; Yoon, W | 1 |
| Chen, J; Duan, J; Ji, X; Li, C; Li, S; Liu, G; Ma, Q; Ren, C; Song, H; Wang, R; Wu, C; Wu, L; Xu, J; Zhao, W | 1 |
| Choi, JW; Hong, JH; Hong, JM; Hwang, YH; Jang, SH; Kang, DH; Kim, CH; Kim, YS; Kim, YW; Lee, JS; Lee, SJ; Park, H; Sohn, SI | 1 |
| Ballotta, E; Baracchini, C; Causin, F; Cester, G; Farina, F; Favaretto, S; Kulyk, C; Nico, L; Palmieri, A; Soso, M; Viaro, F | 1 |
| Che, R; Chen, J; Duan, J; Feng, W; Ji, X; Li, C; Liebeskind, D; Ling, F; Shang, S; Song, H; Wang, Y; Wu, C; Wu, L; Zhang, H; Zhao, W | 1 |
| Feng, W; Huang, SH; Li, W; Li, XS; Liang, CR; Lin, L; Liu, CC; Wang, H; Wang, YJ; Wu, Y; Xu, ZQ; Zhang, LL; Zhang, M | 1 |
| Xiong, W; Yu, YJ | 1 |
| Gao, D; Hu, S; Li, H; Li, M; Wang, H; Zhang, H; Zhu, J | 1 |
| Fang, M; Jin, A; Lin, Y; Liu, X; Yu, T; Zhang, P; Zhou, X | 1 |
| Jiang, L; Lin, L; Parsons, MW; Wu, Y; Yang, J; Yin, C | 1 |
| Berberat, J; Diepers, M; Gruber, P; Hlavica, M; Kahles, T; Nedeltchev, K; Remonda, L; Victor Ineichen, B | 1 |
| Bai, Y; Fan, X; Hao, Y; Li, S; Li, Z; Liu, X; Sun, B; Tian, X; Wang, H; Xu, G; Yang, D; Zhang, M; Zhang, S; Zhang, X; Zi, W | 1 |
| Guo, R; He, J; Liu, J; Shi, Q; Sun, Y; Yang, B; Zhang, C | 1 |
| Chan, PWL; Lin, Y; Pan, X; Yang, J; Zheng, D; Zheng, Y; Zhou, J; Zou, J | 1 |
| Chen, H; Ding, Y; Fang, D; Ju, F; Lu, T; Niu, J; Xue, T; Yin, D; Zhai, T; Zhao, G | 1 |
| Huo, X; Miao, Z; Wang, Y; Yang, M | 1 |
| Chen, TW; Huang, H; Jiang, L; Liu, KQ; Sang, HF; Si, XL; Xia, WQ; Yin, CG | 1 |
| Li, J; Li, X; Luo, Y; Xie, Y; Yang, Y; Yuan, Z | 1 |
| Guo, Y; Lin, Y; Pan, X; Tang, Q; Tang, Y; Wang, X; Yang, J; Zou, J | 1 |
| Bendszus, M; Hacke, W; Hametner, C; Kellert, L; Ringleb, P; Rohde, S; Stampfl, S | 1 |
| Abraha, I; Ciccone, A; Cozzolino, F; Motto, C; Santilli, I | 1 |
| Baik, SK; Hwang, YH; Kang, DH; Kim, YS; Kim, YW; Park, SP | 1 |
| Barry, DM; Dai, XR; Fan, ML; Hou, SX; Jin, H; Kong, F; Lau, LF; Li, TT; Li, XY; Luo, SY; Zhang, GH; Zhou, LL | 1 |
| Chen, SL; Chen, YD; Chen, YG; Cheng, XS; Ge, JB; Han, YL; Jiang, TM; Li, JL; Li, Y; Liang, ZY; Liu, HW; Liu, ML; Ma, LK; Ma, YT; Wang, G; Wang, HY; Xie, Q; Yang, BS; Zhao, X; Zheng, XQ | 1 |
| Bansilal, S; Becker, RC; Cannon, CP; Harrington, RA; Himmelmann, A; Husted, S; James, SK; Katus, HA; Lopes, RD; Neely, B; Shimada, YJ; Steg, PG; Storey, RF; Wallentin, L; Wiviott, SD | 1 |
| Chen, J; Feng, W; Huang, S; Li, W; Li, X; Liang, C; Lin, L; Liu, C; Wang, Y; Wu, Y; Zhang, M | 1 |
| Glahn, J; Philipps, J; Rother, J; Schwarze, M; Thomalla, G | 1 |
| Boiti, C; Borutti, G; Cazzaniga, M; Falaschi, F; Maestroni, A; Mandelli, C; Manganaro, D; Monzani, V; Rossi, P; Torgano, G; Zecca, B; Zilioli, E | 1 |
| Oberstrass, H; Ringelstein, A; Seitz, RJ; Siebler, M; Wittsack, HJ | 1 |
| Baik, SK; Hwang, JC; Kwon, JH; Shin, SH; Weon, YC | 1 |
| Fiebach, JB; Hamann, G; Hennerici, MG; Junghans, U; Röther, J; Schneider, D; Seitz, RJ; Siebler, M; Villringer, A; von Reutern, GM; Witte, OW | 1 |
| Baik, SK; Lee, JH; Oh, SJ; Park, KP | 1 |
| Bang, OY; Byun, HS; Jeon, P; Kim, GM; Kim, JW; Kim, KH | 1 |
| Bassand, JP | 1 |
| Hamzavi, M; Junghans, U; Ringleb, PA; Schranz, C; Seitz, RJ; Siebler, M | 1 |
| Haerten, K; Krabbe, C; Raiber, M | 1 |
| Albuquerque, FC; Deshmukh, VR; Fiorella, DJ; Flaster, M; Frey, J; McDougall, CG; Spetzler, RF; Wallace, RC | 1 |
| Coull, BM; McDonagh, PF; Ritter, LS; Stempel, KM | 1 |
| Dambrink, JH; de Boer, MJ; De Luca, G; Ernst, N; Gosslink, AT; Hoorntje, JC; Ottervanger, JP; Smit, JJ; Suryapranata, H; van 't Hof, AW | 1 |
| Cellerini, M; Gensini, G; Inzitari, D; Mangiafico, S; Nencini, P | 1 |
| Bukow, SC; Daffertshofer, M; Hennerici, MG | 1 |
| Blazing, M; Braunwald, E; Califf, R; Cannon, CP; de Lemos, JA; McCabe, CH; Murphy, SA; Wiviott, SD | 1 |
| Del Pace, S; Scheggi, V | 1 |
| Kent, TA; Mandava, P; Thiagarajan, P | 1 |
| Montalescot, G | 1 |
| Aulich, A; Freund, HJ; Junghans, U; Seitz, RJ; Siebler, M | 1 |
| Cucchiara, BL; Hurst, RW; Liebeskind, DS; McGarvey, ML; Pollard, JR; Schwartz, ED | 1 |
Reviews
15 review(s) available for tirofiban and Stroke
| Article | Year |
|---|---|
Efficacy outcomes and safety measures of intravenous tirofiban or eptifibatide for patients with acute ischemic stroke: a systematic review and meta-analysis of prospective studies.
Topics: Brain Ischemia; Eptifibatide; Humans; Ischemic Stroke; Prospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Early tirofiban administration for patients with acute ischemic stroke treated with intravenous thrombolysis or bridging therapy: Systematic review and meta-analysis.
Topics: Administration, Intravenous; Brain Ischemia; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2022 |
Tirofiban for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.
Topics: Brain Ischemia; Endovascular Procedures; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2023 |
Meta-analysis of the efficacy and safety of tirofiban in patients with acute ischaemic stroke undergoing mechanical thrombectomy.
Topics: Brain Ischemia; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Safety and efficacy of tirofiban in the management of stroke: A systematic review and meta-analysis of randomized controlled trials.
Topics: Brain Ischemia; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Treatment Outcome | 2023 |
Systematic review and meta-analysis of the efficacy and safety of adjunctive use of tirofiban in patients treated with endovascular therapy for acute ischemic stroke at different embolic sites.
Topics: Brain Ischemia; Endovascular Procedures; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Tirofiban for acute ischemic stroke: systematic review and meta-analysis.
Topics: Brain Ischemia; Humans; Injections, Intra-Arterial; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Treatment Outcome | 2020 |
Safety and Efficacy of Tirofiban in Acute Ischemic Stroke Patients Receiving Endovascular Treatment: A Meta-Analysis.
Topics: Brain Ischemia; Endovascular Procedures; Hemorrhage; Humans; Patient Safety; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Time Factors; Tirofiban; Treatment Outcome | 2020 |
Safety and efficacy of tirofiban combined with endovascular therapy compared with endovascular therapy alone in acute ischemic stroke: a meta-analysis.
Topics: Brain Ischemia; Endovascular Procedures; Humans; Ischemic Stroke; Prospective Studies; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2021 |
Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke.
Topics: Brain Ischemia; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Stroke Rehabilitation; Thrombosis; Tirofiban | 2019 |
Safety and efficacy of early antiplatelet therapy in acute ischemic stroke patients receiving endovascular treatment: A systematic review and meta-analysis.
Topics: Brain Ischemia; Endovascular Procedures; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2019 |
Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Brain Ischemia; Humans; Immunoglobulin Fab Fragments; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Tyrosine | 2014 |
Tirofiban for the treatment of ischaemic stroke.
Topics: Animals; Brain Ischemia; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Tyrosine | 2006 |
Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.
Topics: Abciximab; Acute Disease; Animals; Antibodies, Monoclonal; Brain Ischemia; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Tyrosine | 2008 |
Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease.
Topics: Arteriosclerosis; Clopidogrel; Eptifibatide; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Tirofiban; Tyrosine | 2000 |
Trials
19 trial(s) available for tirofiban and Stroke
| Article | Year |
|---|---|
Endovascular treatment with versus without tirofiban for stroke patients with large vessel occlusion: The multicenter, randomized, placebo-controlled, double-blind RESCUE BT study protocol.
Topics: Arterial Occlusive Diseases; Double-Blind Method; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2022 |
Efficacy and safety assessment of urokinase plus tirofiban in acute cerebral infarction patients without clear criminal vessels.
Topics: Acute Disease; Brain Ischemia; C-Reactive Protein; Cerebral Infarction; Criminals; Humans; Interleukin-6; Stroke; Tirofiban; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator | 2022 |
Endovascular Recanalization for Acute Internal Carotid Artery Terminus Occlusion: A Subgroup Analysis From the Direct-MT Trial.
Topics: Arterial Occlusive Diseases; Carotid Artery Diseases; Carotid Artery, Internal; Endovascular Procedures; Humans; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Arterial Occlusive Diseases; Brain Ischemia; Double-Blind Method; Endovascular Procedures; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Platelet Aggregation Inhibitors; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2022 |
RESCUE BT 2, a multicenter, randomized, double-blind, double-dummy trial of intravenous tirofiban in acute ischemic stroke: Study rationale and design.
Topics: Aspirin; Double-Blind Method; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2023 |
The efficacy and safety of intravenous tirofiban in the treatment of acute ischemic stroke patients with early neurological deterioration.
Topics: Brain Ischemia; Humans; Ischemic Stroke; Stroke; Tirofiban; Treatment Outcome | 2022 |
Analysis of risk factors for the efficacy of tirofiban in the treatment of acute ischemic stroke.
Topics: Brain Ischemia; Cholesterol; Fibrinolytic Agents; Humans; Ischemic Stroke; Retrospective Studies; Risk Factors; Stroke; Tirofiban; Treatment Outcome | 2023 |
Association between intravenous tirofiban and intracranial hemorrhage in acute large vessel occlusion stroke: insight from the RESCUE BT randomized placebo-controlled trial.
Topics: Aged; Brain Ischemia; Endovascular Procedures; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Association of Tirofiban With Functional Outcomes After Thrombectomy in Acute Ischemic Stroke Due to Intracranial Atherosclerotic Disease.
Topics: Aged; Brain Ischemia; Endovascular Procedures; Female; Humans; Intracranial Arteriosclerosis; Ischemic Stroke; Male; Middle Aged; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Intravenous tirofiban following successful reperfusion in intracranial large artery atherosclerotic stroke: A secondary analysis of a randomized clinical trial.
Topics: Arteries; Brain Ischemia; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Reperfusion; Stroke; Tirofiban; Treatment Outcome | 2023 |
Association of tirofiban treatment with outcomes following endovascular therapy in cardioembolic stroke: insights from the RESCUE BT randomized trial.
Topics: Brain Ischemia; Embolic Stroke; Endovascular Procedures; Humans; Intracranial Hemorrhages; Stroke; Tirofiban; Treatment Outcome | 2023 |
Clinical efficacy of tirofiban combined with a Solitaire stent in treating acute ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Cerebral Revascularization; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Stents; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2019 |
Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
Topics: Aged; Brain Ischemia; China; Disability Evaluation; Drug Administration Schedule; Female; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Quality of Life; Recovery of Function; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome | 2019 |
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Topics: Abciximab; Acute Coronary Syndrome; Adenosine; Aged; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Tirofiban; Tyrosine | 2016 |
Treatment of progressive stroke with tirofiban--experience in 35 patients.
Topics: Aged; Arterial Occlusive Diseases; Disease Progression; Female; Humans; Injections, Intravenous; Male; Microcirculation; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Chi-Square Distribution; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Fibrinolytic Agents; Hospital Mortality; Humans; Intracranial Hemorrhages; Italy; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recovery of Function; Stroke; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2010 |
Failed recovery from thrombolysis is predicted by the initial diffusion weighted imaging lesion.
Topics: Aged; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Recovery of Function; Severity of Illness Index; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Tyrosine | 2011 |
Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Radiography; Stroke; Time Factors; Tirofiban; Tyrosine | 2011 |
Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study.
Topics: Adult; Aged; Aged, 80 and over; Cerebral Hemorrhage; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2001 |
Other Studies
58 other study(ies) available for tirofiban and Stroke
| Article | Year |
|---|---|
Effect of Tirofiban on new cerebral microbleeds after mechanical thrombectomy in patients with acute ischemic stroke.
Topics: Brain Ischemia; Cerebral Hemorrhage; Fibrinolytic Agents; Humans; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2021 |
Conservative versus aggressive antiplatelet strategy for emergent carotid stenting during stroke thrombectomy.
Topics: Aspirin; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
[Safety and efficacy of intra-arterial tirofiban infusion in patients with acute cardiogenic cerebral embolism undergoing endovascular reperfusion therapy].
Topics: Humans; Intracranial Embolism; Reperfusion; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Effect of tirofiban in treating patients with progressive ischemic stroke.
Topics: Cerebral Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Balloon Angioplasty Combined with Tirofiban as a First-Line Rescue Treatment After Failed Mechanical Thrombectomy for Middle Cerebral Artery Occlusion with Underlying Atherosclerosis.
Topics: Angioplasty; Angioplasty, Balloon; Atherosclerosis; Constriction, Pathologic; Humans; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2022 |
Safety and efficacy of different tirofiban administration routes on acute ischemic stroke patients with successful recanalization: A propensity score matching analysis.
Topics: Brain Ischemia; Cohort Studies; Humans; Intracranial Hemorrhages; Ischemic Stroke; Propensity Score; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Safety Profile and Complication Rates in Emergency Off-label Use of Tirofiban in Interventional Neuroradiology : An Observational Dual Center Study.
Topics: Adult; Aged; Aged, 80 and over; Fibrinolytic Agents; Humans; Ischemic Stroke; Middle Aged; Off-Label Use; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2023 |
Association of Intravenous Tirofiban with Functional Outcomes in Acute Ischemic Stroke Patients with Acute Basilar Artery Occlusion Receiving Endovascular Thrombectomy.
Topics: Basilar Artery; Humans; Intracranial Hemorrhages; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Influence of tirofiban on stroke outcome after mechanical thrombectomy in acute vertebrobasilar artery occlusion.
Topics: Arterial Occlusive Diseases; Arteries; Brain Ischemia; Cerebral Hemorrhage; Hospital Mortality; Humans; Ischemic Stroke; Retrospective Studies; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2022 |
Effects of Antecedent Intravenous Thrombolysis on Endovascular Treatment of Acute Stroke Using Tirofiban.
Topics: Brain Ischemia; Cerebral Hemorrhage; Fibrinolytic Agents; Humans; Ischemic Stroke; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2023 |
Factors affecting the outcomes of tirofiban after endovascular treatment in acute ischemic stroke: Experience from a single center.
Topics: Brain Ischemia; Endovascular Procedures; Humans; Ischemic Stroke; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2023 |
Comparison of Safety and Efficacy after Emergency Stenting in Patients Exhibiting Intracranial Atherosclerotic Stenosis Associated with Large-vessel Occlusion with and without Intravenous Infusion of Tirofiban.
Topics: Brain Ischemia; Constriction, Pathologic; Endovascular Procedures; Humans; Infusions, Intravenous; Intracranial Arteriosclerosis; Retrospective Studies; Stents; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
Safety and Efficacy of Tirofiban Bridging Therapy During a Hybrid Carotid Artery Stenting and Off-pump Coronary Artery Bypass Grafting Surgery: A Single-center Study.
Topics: Carotid Arteries; Carotid Stenosis; Coronary Artery Bypass; Coronary Artery Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Stroke; Tirofiban; Treatment Outcome | 2023 |
Tirofiban in the treatment of cancer-associated ischemic stroke.
Topics: Aspirin; Brain Ischemia; Humans; Ischemic Stroke; Neoplasms; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2023 |
Association of tirofiban with improvement of functional outcomes of direct thrombectomy for acute anterior circulation occlusion: a retrospective, nonrandomized, multicenter, real-world study.
Topics: Brain Ischemia; Cerebral Hemorrhage; Endovascular Procedures; Humans; Ischemic Stroke; Male; Retrospective Studies; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |
In ischemic stroke without large or medium vessel occlusion, tirofiban increased likelihood of an excellent outcome.
Topics: Brain Ischemia; Humans; Ischemic Stroke; Stroke; Tirofiban; Treatment Outcome | 2023 |
Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis.
Topics: Aged; Disease Progression; Female; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome | 2019 |
Efficacy and Safety of Low-Dose Tirofiban for Acute Intracranial Atherosclerotic Stenosis Related Occlusion with Residual Stenosis after Endovascular Treatment.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Disability Evaluation; Endovascular Procedures; Female; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Recovery of Function; Recurrence; Retrospective Studies; Risk Factors; Stroke; Time Factors; Tirofiban; Treatment Outcome | 2020 |
Low-dose rescue tirofiban in mechanical thrombectomy for acute cerebral large-artery occlusion.
Topics: Arteries; Brain Ischemia; Fibrinolytic Agents; Humans; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2020 |
Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
Topics: Administration, Intravenous; Administration, Oral; Aged; Brain Ischemia; Disability Evaluation; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recovery of Function; Retrospective Studies; Risk Factors; Stroke; Time Factors; Tirofiban; Treatment Outcome | 2020 |
Microcatheter infusion of bolus-dose tirofiban for acute ischemic stroke due to distal intracranial artery occlusion.
Topics: Aged; Computed Tomography Angiography; Female; Fibrinolytic Agents; Humans; Intracranial Arterial Diseases; Magnetic Resonance Angiography; Male; Middle Aged; Retrospective Studies; Stroke; Thrombolytic Therapy; Tirofiban | 2020 |
Safety and Efficacy of Tirofiban During Mechanical Thrombectomy for Stroke Patients with Preceding Intravenous Thrombolysis.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Male; Mechanical Thrombolysis; Middle Aged; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2020 |
Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke.
Topics: Aged; Brain Ischemia; Combined Modality Therapy; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Registries; Retrospective Studies; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2020 |
Increased Rates of Hemorrhages after Endovascular Stroke Treatment with Emergency Carotid Artery Stenting and Dual Antiplatelet Therapy.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Cerebral Hemorrhage; Dual Anti-Platelet Therapy; Emergencies; Endovascular Procedures; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Stroke; Thrombectomy; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome | 2021 |
Intravenous Tirofiban Infusion After Angioplasty and Stenting in Intracranial Atherosclerotic Stenosis-Related Stroke.
Topics: Administration, Intravenous; Aged; Angioplasty; Female; Follow-Up Studies; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Retrospective Studies; Stents; Stroke; Thrombectomy; Tirofiban | 2021 |
Low-dose tirofiban is associated with reduced in-hospital mortality in cardioembolic stroke patients treated with endovascular thrombectomy.
Topics: Brain Ischemia; Embolic Stroke; Endovascular Procedures; Fibrinolytic Agents; Hospital Mortality; Humans; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2021 |
The Safety of Intra-arterial Tirofiban during Endovascular Therapy after Intravenous Thrombolysis.
Topics: Brain Ischemia; Endovascular Procedures; Fibrinolytic Agents; Humans; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2021 |
Stentriever Thrombectomy Failure: A Challenge in Stroke Management.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Angiography; Computed Tomography Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Intracranial Hemorrhages; Magnetic Resonance Angiography; Male; Middle Aged; Mortality; Prospective Studies; Stents; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Treatment Outcome; Tyrosine; Ultrasonography, Doppler, Transcranial | 2017 |
Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy.
Topics: Aged, 80 and over; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Endpoint Determination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Registries; Risk Factors; Stroke; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Brain; Brain Ischemia; Cerebral Angiography; Cerebral Hemorrhage; Computed Tomography Angiography; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Incidence; Male; Middle Aged; Proof of Concept Study; Stroke; Time Factors; Time-to-Treatment; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
Tirofiban combined with rt-PA intraarterial thrombolysis improves the recanalization rate of acute middle cerebral artery occlusion in rabbits.
Topics: Acute Disease; Animals; Brain Ischemia; Drug Therapy, Combination; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Male; Rabbits; Random Allocation; Recombinant Proteins; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome | 2018 |
Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Topics: Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon, Coronary; Catheters; Drug Administration Routes; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardium; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2018 |
Safety and Efficiency of Low Dose Intra-arterial Tirofiban in Mechanical Thrombectomy During Acute Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Brain; Brain Ischemia; Cohort Studies; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Male; Middle Aged; Severity of Illness Index; Stroke; Tirofiban; Tissue Plasminogen Activator; Tomography Scanners, X-Ray Computed; Treatment Outcome | 2018 |
Endovascular Thrombectomy.
Topics: Aged; Aged, 80 and over; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Stroke; Thrombectomy; Tirofiban | 2018 |
Acute administration of tirofiban versus aspirin in emergent carotid artery stenting.
Topics: Aged; Aspirin; Carotid Stenosis; Cerebral Angiography; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Retrospective Studies; Stents; Stroke; Tirofiban; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Safety of Intra-Arterial Tirofiban Administration in Ischemic Stroke Patients after Unsuccessful Mechanical Thrombectomy.
Topics: Aged; Brain Ischemia; China; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Intracranial Hemorrhages; Male; Middle Aged; Recovery of Function; Registries; Retrospective Studies; Risk Factors; Stroke; Thrombectomy; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome | 2019 |
Safety and efficacy of tirofiban combined with endovascular treatment in acute ischaemic stroke.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Combined Modality Therapy; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Prospective Studies; Registries; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome | 2019 |
The efficacy and safety of tirofiban for patients with acute ischemic stroke: A protocol for systematic review and a meta-analysis.
Topics: Acute Disease; Brain Ischemia; Case-Control Studies; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Research Design; Stroke; Systematic Reviews as Topic; Tirofiban; Treatment Outcome | 2019 |
Mechanical Thrombectomy Using Solitaire in Acute Ischemic Stroke Patients with Vertebrobasilar Occlusion: A Prospective Observational Study.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Multivariate Analysis; Postoperative Hemorrhage; Prognosis; Prospective Studies; Stroke; Thrombectomy; Time-to-Treatment; Tirofiban; Tomography, X-Ray Computed; Vertebrobasilar Insufficiency | 2019 |
Therapeutic effect of pre-operative tirofiban on patients with acute ischemic stroke with mechanical thrombectomy within 6-24 hours.
Topics: Aged; Brain Ischemia; Cerebral Angiography; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Premedication; Retrospective Studies; Stroke; Thrombectomy; Tirofiban; Tomography, X-Ray Computed | 2019 |
Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome.
Topics: Aged; Aged, 80 and over; Cerebral Hemorrhage; Combined Modality Therapy; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Risk; Stroke; Thrombectomy; Tirofiban; Tyrosine | 2013 |
Instant reocclusion following mechanical thrombectomy of in situ thromboocclusion and the role of low-dose intra-arterial tirofiban.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Brain; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 2014 |
A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.
Topics: Animals; Bleeding Time; Blood Platelets; Brain Ischemia; Cell Count; Cerebral Hemorrhage; Crotalid Venoms; Dose-Response Relationship, Drug; Fibrin; Infarction, Middle Cerebral Artery; Lectins, C-Type; Male; Mice; Platelet Glycoprotein GPIb-IX Complex; Protective Agents; Reperfusion Injury; Stroke; Tirofiban; Tyrosine; von Willebrand Factor | 2015 |
[A large-scale, multicenter, retrospective study on efficacy of bivalirudin use during peri-percutaneous coronary intervention period for Chinese patients with coronary heart disease].
Topics: Aged; China; Coronary Disease; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Peptide Fragments; Percutaneous Coronary Intervention; Recombinant Proteins; Retrospective Studies; Stroke; Tirofiban; Tyrosine | 2016 |
Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
Topics: Aged; Brain; Brain Ischemia; Drug Administration Schedule; Female; Fibrinolytic Agents; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine | 2016 |
Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Recovery of Function; Retrospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2011 |
Intra-arterial tirofiban infusion for partial recanalization with stagnant flow in hyperacute cerebral ischemic stroke.
Topics: Acute Disease; Adult; Blood Flow Velocity; Brain Ischemia; Cerebral Angiography; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2011 |
Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: preliminary experience and short term follow-up results.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Feasibility Studies; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Intracranial Hemorrhages; Male; Middle Aged; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2012 |
[Platelet antiaggregation treatment in the aftermath of GUSTO IV, TARGET, TACTICS, and CURE trials].
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Coronary Artery Bypass; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Time Factors; Tirofiban; Tyrosine | 2002 |
Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.
Topics: Acute Disease; Aged; Case-Control Studies; Drug Therapy, Combination; Feasibility Studies; Fibrinolytic Agents; Humans; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Retrospective Studies; Severity of Illness Index; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine | 2003 |
[Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice].
Topics: Adult; Aged; Anticoagulants; Aspirin; Brain; Brain Ischemia; Carotid Arteries; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Eptifibatide; Female; Heparin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stroke; Ticlopidine; Tirofiban; Tomography, X-Ray Computed; Tyrosine; Ultrasonography, Doppler | 2004 |
Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy.
Topics: Abciximab; Acute Disease; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Brain Ischemia; Chemotherapy, Adjuvant; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tyrosine | 2005 |
Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion.
Topics: Analysis of Variance; Animals; Anticoagulants; Biomarkers; Blood Platelets; Brain Ischemia; Disease Models, Animal; Flow Cytometry; Inflammation; Leukocytes; Male; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Polysaccharides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Severity of Illness Index; Stroke; Time Factors; Tirofiban; Tyrosine | 2005 |
Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.
Topics: Aged; Angiography; Angioplasty, Balloon, Coronary; Female; Fibrinolytic Agents; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Perfusion; Stroke; Time Factors; Tirofiban; Tyrosine | 2005 |
Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases.
Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Catheterization; Combined Modality Therapy; Female; Heparin; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Hemorrhages; Male; Middle Aged; Risk; Severity of Illness Index; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2005 |
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Case Management; Chemical and Drug Induced Liver Injury; Comorbidity; Confounding Factors, Epidemiologic; Dose-Response Relationship, Drug; Endpoint Determination; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Tables; Lipids; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Simvastatin; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2006 |
Acute ischaemic stroke treated with combined intra-arterial thrombolysis and intravenous tirofiban despite oral anticoagulant therapy at an international normalised ratio > or = 2.0.
Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Brain Ischemia; Contraindications; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Patient Selection; Stroke; Thrombolytic Therapy; Tirofiban; Tyrosine | 2006 |
Vertebrobasilar thrombolysis with intravenous tirofiban: case report.
Topics: Aged; Arterial Occlusive Diseases; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine; Vertebrobasilar Insufficiency | 2002 |